Just got offer from Guggenheim, wanted to know what the top groups were (even within groups for example biopharma vs med tech vs services in HC) as well as probable and possible exits from various groups.
| +170 | Evercore > Goldman and I don’t think it’s particularly close anymore | 62 | 34m |
| +152 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 15h |
| +124 | I am a drunk MD AMA | 40 | 1d |
| +86 | UBS Offer Day | 30 | 1d |
| +75 | Santander IB? | 10 | 3d |
| +71 | I hate Wells Fargo | 19 | 17h |
| +51 | No return offer - feeling like a failure is an understatement | 20 | 12h |
| +50 | Think Twice before Recruiting for HOUSTON IB!! | 18 | 3m |
| +45 | How cooked am I as an incoming WF IB SA 2027? | 17 | 8h |
| +43 | WF Return offers | 28 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
Recent exits from Gugg: Advent, HIG (multiple), BX, BX Growth, KKR (multiple), Carlyle (multiple), TA Associates as far as big time places. These are recent exits, obviously not all from this year
What are you smokin’?
Elaborate?
Blatantly false
theyre medtech / med devices group tops the street; think it used to fall under services group but not sure now
sweaty as fuck overall would not recommend for the exits quality
.
shoot me a DM - in the same spot
Dmd u
Top groups are HC Services, Biopharma, TMT, Industrials
Placements this year included Carlyle, Cove Hill, GTCR, MDP, Oaktree, THL, WCAS (probably missing a few / many analysts participating in off-cycle)
Previous years included Advent, BX, Carlyle, Golden Gate, KKR, Siris, TA
work here, this is is accurate for this year on-cycle
accurate for top groups as well?
Has the sentiment on medtech changed? You didn’t list in your top groups even though they’ve been regarded very highly in the recent years. Just wondering what’s changed
Structured Products is a great group. Probably the best group for Esoteric ABS. They are filled with Lehman/Barclays bankers from the old days and turn anything into a security. Hours are bad but exits are top notch. AFter building models based on 10 page waterfalls for 2-3 years, you'll have the skillset to model any product in existence.
Ahh yes the old days of esoteric ABS
It's a good bank that pays well. Definitely an offer worth considering. HC and TMT are strong groups. I'd say their trajectory looks solid. I'd view Jefferies and Greenhill as their best comps (latter trending downward but still exiting well). I wouldn't say they are quite at the same level as PWP / MOE / LAZ but they are still great.
FWIW, I work at a UMM fund that hired a Guggenheim analyst during this past on cycle process (top group, target school, perfect stats, etc.) and interviewed a few more (all from HC / Biopharma / TMT). Think we still tend to interview more kids from mid-tier BBs like Barclays though.
Any thoughts on medtech team? Seem to be a top group in the space but see you didn’t mention them
RX group has good exits, including Monarch, Beachpoint, CVC, Lonestar, Melvin (RIP), Caspian, Diameter, PIMCO, etc.
Any updates on Gugg placement this past on-cycle? Heard there were some CD&R placements
Rerum dolorem deserunt illo tenetur earum quia aperiam. Aut aut placeat magnam sint voluptatem placeat. Praesentium quibusdam sed ex ea minima consectetur.
Reiciendis natus aspernatur maxime molestiae quam inventore. Et veritatis ad porro possimus voluptatum. Saepe rerum ut et minus.
Adipisci animi est minus enim unde neque odio. Quibusdam velit exercitationem quas. Quod assumenda ullam eligendi perspiciatis molestias.
Placeat suscipit hic omnis officiis. Eligendi quia voluptas earum ut nulla et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...